Polar Capital Holdings PLC Xenon Pharmaceuticals Inc. Transaction History

Polar Capital Holdings PLC

$16.3 Billion
Q3 2024

A detailed history of Polar Capital Holdings PLC transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Polar Capital Holdings PLC holds 2,444,645 shares of XENE stock, worth $95.1 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares

2,444,645

Previous 2,536,058 3.6%

Holding current value

$95.1 Million

Previous $98.9 Million 2.71%

% of portfolio

0.59%

Previous 0.6%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$36.12 - $43.96 $3.3 Million - $4.02 Million	-91,413 Reduced 3.6%	2,444,645 $96.2 Million
Q2 2024 Aug 14, 2024	SELL	$36.25 - $43.75 $2.76 Million - $3.33 Million	-76,050 Reduced 2.91%	2,536,058 $98.9 Million
Q1 2024 May 15, 2024	SELL	$42.66 - $50.04 $19.4 Million - $22.7 Million	-454,520 Reduced 14.82%	2,612,108 $112 Million
Q4 2023 Feb 14, 2024	BUY	$28.7 - $46.46 $1.8 Million - $2.92 Million	62,881 Added 2.09%	3,066,628 $141 Million
Q3 2023 Nov 14, 2023	SELL	$34.16 - $39.73 $625,947 - $728,012	-18,324 Reduced 0.61%	3,003,747 $103 Million
Q2 2023 Dec 13, 2023	BUY	$34.84 - $43.54 $183,014 - $228,715	5,253 Added 0.17%	3,022,071 $116 Million
Q2 2023 Aug 14, 2023	BUY	$34.84 - $43.54 $105 Million - $132 Million	3,022,071 New	3,022,071 $116 Million
Q1 2023 Dec 13, 2023	BUY	$33.46 - $40.35 $437,355 - $527,414	13,071 Added 0.44%	3,016,818 $108 Million
Q4 2022 Feb 14, 2023	BUY	$33.06 - $39.43 $12.7 Million - $15.1 Million	383,152 Added 14.39%	3,045,874 $120 Million
Q3 2022 Nov 14, 2022	BUY	$30.79 - $39.82 $3.78 Million - $4.88 Million	122,663 Added 4.83%	2,662,722 $96.1 Million
Q2 2022 Aug 15, 2022	BUY	$25.44 - $35.16 $8.9 Million - $12.3 Million	350,000 Added 15.98%	2,540,059 $77.3 Million
Q1 2022 May 16, 2022	BUY	$25.09 - $33.13 $12.6 Million - $16.6 Million	502,015 Added 29.74%	2,190,059 $67 Million
Q4 2021 Feb 14, 2022	BUY	$15.6 - $35.4 $26.3 Million - $59.8 Million	1,688,044 New	1,688,044 $52.7 Million

Others Institutions Holding XENE

# of Institutions

212

Shares Held

70.2M

Call Options Held

88.3K

Put Options Held

28.8K

View Full List

About Xenon Pharmaceuticals Inc.

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.42B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

More about XENE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Polar Capital Holdings PLC with notifications on news.

Account

Polar Capital Holdings PLC Xenon Pharmaceuticals Inc. Transaction History